Supernus Pharmaceuticals | SUPN - Biaya Operasional





Biaya Operasional Perubahan Tanggal
Abbott USD 9.31B 104M 2026-03
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Canopy Growth CAD 87.2M 6.22M 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Eisai JPY 215.74B 15.84B 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Novo Nordisk DKK 37.21B 9.56B 2026-03
Pacira USD 172.75M 20.93M 2026-03
Perrigo USD 935.6M 89.6M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
United Therapeutics USD 5.9B 5.1B 2026-03
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12